Latest Updates

To ensure optimal utilisation of clinical pharmacology units (CPUs) that conduct bio-equivalence studies, the company is…

The facility was inspected by the US Food and Drug Administration (US FDA) between May 6-15, 2019, Lupin said in a BSE filing

NCLAT stated that although Sterling Biotech, which is presently going through liquidation, is not the owner of the premises it…

Parkinson's disease and multiple sclerosis are neurodegenerative illnesses that damage the brain and central nervous system. The…

"Sangita was appointed as an independent director of the company for a period of five years at the 23rd annual general meeting…

For ACG Engineering, the acquisition provides a strong injection of European design into its capabilities roster, as the Xertecs…

Korean pharmaceutical exports have become attractive due to competitive pricing in the generics market and, as a result, Korean…

The event, which will be attended by top experts from across the globe, will be focused on the day to day practices of managing…

Ogivri is the first trastuzumab biosimilar approved and launched in Australia and available on the Pharmaceutical Benefits Scheme…

The partnership is a strategic step towards co-development of world-class healthcare technologies completely indigenously under…